Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
QuintilesIMS
Cantor Fitzgerald
Dow
Chinese Patent Office
McKinsey
Johnson and Johnson
UBS
Medtronic

Generated: October 23, 2017

DrugPatentWatch Database Preview

LEVOCARNITINE Drug Profile

« Back to Dashboard

Which patents cover Levocarnitine, and what generic Levocarnitine alternatives are available?

Levocarnitine is a drug marketed by Lyne, Impax Labs Inc, Luitpold, West-ward Pharms Int, Teva Pharms Usa, and Hi Tech Pharma. and is included in six NDAs.

The generic ingredient in LEVOCARNITINE is levocarnitine. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levocarnitine profile page.

Summary for Tradename: LEVOCARNITINE

US Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list2
Bulk Api Vendors: see list52
Clinical Trials: see list5
Patent Applications: see list3,392
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEVOCARNITINE at DailyMed

Pharmacology for Tradename: LEVOCARNITINE

Ingredient-typeCarnitine
Drug ClassCarnitine Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lyne
LEVOCARNITINE
levocarnitine
SOLUTION;ORAL076851-001Aug 10, 2004AARXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
LEVOCARNITINE
levocarnitine
INJECTABLE;INJECTION075567-001Mar 29, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
LEVOCARNITINE
levocarnitine
TABLET;ORAL076858-001Sep 20, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Luitpold
LEVOCARNITINE
levocarnitine
INJECTABLE;INJECTION075861-001Jun 22, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
Hi Tech Pharma
LEVOCARNITINE
levocarnitine
SOLUTION;ORAL077399-001Oct 25, 2007AARXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
LEVOCARNITINE
levocarnitine
INJECTABLE;INJECTION075881-001Mar 29, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKesson
Teva
Harvard Business School
Novartis
QuintilesIMS
Fuji
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot